Does TREPROSTINIL Cause Infusion site thrombosis? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Infusion site thrombosis have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
21
Reports of Infusion site thrombosis with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
1
Deaths
11
Hospitalizations
How Dangerous Is Infusion site thrombosis From TREPROSTINIL?
Of the 21 reports, 1 (4.8%) resulted in death, 11 (52.4%) required hospitalization.
Is Infusion site thrombosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Infusion site thrombosis?
MESALAMINE (16)
AZATHIOPRINE (15)
FIBRINOGEN HUMAN (15)
RANITIDINE (15)
ESOMEPRAZOLE (14)
HUMAN IMMUNOGLOBULIN G (13)
AMLODIPINE (12)
GEMCITABINE (10)
SODIUM (9)
ASPIRIN (8)
Which TREPROSTINIL Alternatives Have Lower Infusion site thrombosis Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE